Ghana Pharmaceuticals and Healthcare Report Q2 2010

Dallas, TX: ReportsandReports announce it will carry Ghana Pharmaceuticals and Healthcare Report Q2 2010 Market Research Report in its Store.

BMI’s new Ghana pharmaceuticals and healthcare report includes top-line pharmaceutical market and healthcare spending data through to 2019, including our views on growth drivers in this sector. Pharmaceutical spending in Ghana is expected to rise at a compound annual growth rate (CAGR) of 21.8% from 2009 to reach GHC550mn (US$537mn) by 2014. Per-capita spending on medicines will increase from US$8.40 in 2009 to US$20.42 by 2014. While oil revenues are expected to massively increase GDP from 2011 onwards, BMI expects the distribution of income to bring about only modest rises in per-capita expenditure, including spending on essentials like pharmaceuticals.

The Ghana Pharmaceutical Manufacturing Association (GPMA) has revealed that there are significant challenges to the development of a regional drug production base in the country. The announcement came at a meeting in which local manufacturers discussed ways of developing their competencies to include a range of generic medicines - potentially leading to better access to health and increased exports. A report published by a Germany-based international cooperation organisation, featuring chapters written by the Ghana National Drugs Programme, highlighted concerns over current pharmaceutical production in the country. According to the report, around 70% of medicines in Ghana are imported, with the majority coming from India and China. This is to be expected given that these countries mainly produce generic drugs, which are preferred by governments in developing countries as a cost-saving measure. In terms of West Africa, Nigeria produces and exports approximately 30% of the region’s drugs. Notably, a number of West African countries are Francophone, with a therefore unsurprising import reliance on French medicines.

Healthcare in Ghana is gradually improving. According to the World Health Organization (WHO), total spending on healthcare in the country was GHC1.16bn (US$1.25bn) in 2007. However, government spending in this sector, as a percentage of the total, still needs to increase - it stood at only 51.6% in 2007. Although government contributions as a proportion have been erratic, we believe that the percentages will increase in the next few years, particularly as a result of the continued investment in the subsidised health insurance scheme.

Executive Summary
SWOT Analysis
Ghana Pharmaceutical and healthcare SWOT
Ghana Political SWOT
Ghana Economic SWOT
Ghana Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Middle East And Africa (MEA) - Regional Pharmaceutical Business Environment Ratings, Q210
Limits Of Potential Returns
Risks To Realisation Of Returns
Market Summary
Regulatory Regime
mPedigree’s Activities In Ghana - Low-Cost Detection And Interception Technology
Pricing And Reimbursement
Intellectual Property Regime
Macroeconomic Forecast

Table: Ghana - Economic Activity
Industry Forecast Scenario
Overall Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Pharmaceutical Industry Trends and Developments
Epidemiology
Clinical Trials Sector
Competitive Landscape
Company Profiles
LaGray Chemical Company
Historical D
DanAdams Pharmaceutical Industry
BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview

Table: Pharmaceutical Business Environment Indicators
Weighting

Table: Weighting Of Components
Sources
Forecast Tables

Browse all Ghana Pharmaceuticals and Healthcare Report Q2 2010 report at: https://www.reportsandreports.com/market-reports/ghana-pharmaceuticals-and-healthcare-report-q2-2010/

Browse Business Monitor International report at:
www.reportsandreports.com/Publishers/business-monitor-international/

Related Reports:

www.reportsandreports.com/market-reports/cambodia-pharmaceuticals-and-healthcare-report-q2-2010/

www.reportsandreports.com/market-reports/sweden-pharmaceuticals-and-healthcare-report-q2-2010/

www.reportsandreports.com/market-reports/central-america-pharmaceuticals-and-healthcare-report-q2-2010/

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website:  www.reportsandreports.com/
Blog: reportsnreports.wordpress.com/